Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
Iwase, H, Yamamoto, Y, Yamamoto-Ibusuki, M, Murakami, K-I, Okumura, Y, Tomita, S, Inao, T, Honda, Y, Omoto, Y, Iyama, K-I
Published in British journal of cancer (17.09.2013)
Published in British journal of cancer (17.09.2013)
Get full text
Journal Article
“BRCAness”; a potential predictor needing the additional therapeutics
Yamamoto-Ibusuki, M, Yamamoto, Y, Fujiki, Y, Sueta, A, Takeshita, T, Tomiguchi, M, Goto, L, Nishiumura, J, Iwase, H
Published in Breast (Edinburgh) (01.03.2017)
Published in Breast (Edinburgh) (01.03.2017)
Get full text
Journal Article
Abstract P6-09-06: BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study
Kosaka, Y, Yamamoto, Y, Nishimiya, H, Ibusuki-Yamamoto, M, Hirota, Y, Tanino, H, Iwase, H, Nakamura, S, Akashi-Tanaka, S
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P1-02-09: Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients
Takeshita, T, Yamamoto, Y, Yamamoto-Ibusuki, M, Sueta, A, Tomiguchi, M, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P6-07-07: Clinical significance of ESR1 mutations using droplet digital polymerase chain reaction assay in 325 breast cancer samples
Takeshita, T, Yamamoto, Y, Yamamoto-Ibusuki, M, Inao, T, Sueta, A, Fujiwara, S, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P3-07-11: High activation of PI3K pathway defined by PIK3CA mutation, PTEN, and INPP4B expression are associated with trastuzumab efficacy in HER2-positive breast cancer
Sueta, A, Yamamoto, Y, Takeshita, T, Yamamoto-Ibusuki, M, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P6-09-46: A comprehensive analysis of GNAS DNA copy number, levels of mRNA and protein expression in primary breast cancer
Tomiguchi, M, Yamamoto, Y, Yamamoto-Ibusuki, M, Goto-Yamaguchi, L, Fujiki, Y, Sueta, A, Takeshita, T, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P6-09-48: Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
Fujiki, Y, Yamamoto, Y, Yamamoto-Ibusuki, M, Goto, R, Tomiguchi, M, Sueta, A, Takeshita, T, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P4-09-01: FGFR1 protein expression is associated with prognosis in primary breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression
Tomiguchi, M, Yamamoto, Y, Yamamoto-Ibusuki, M, Yamaguchi, R, Fujiki, Y, Fujiwara, S, Sueta, A, Takeshita, T, Inao, T, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P1-14-04: Subsequent endocrine therapy after becoming to resistance of ‘estrogen therapy’ is beneficial as a salvage treatment for the late stage metastatic breast cancer
Iwase, H, Yamamoto, Y, Yamamoto-Ibusuki, M, Murakami, K-I, Inao, T, Okumura, Y, Omoto, Y
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
P256 - “BRCAness”; a potential predictor needing the additional therapeutics
Yamamoto-Ibusuki, M., Yamamoto, Y., Fujiki, Y., Sueta, A., Takeshita, T., Tomiguchi, M., Goto, L., Nishiumura, J., Iwase, H.
Published in Breast (Edinburgh) (01.03.2017)
Published in Breast (Edinburgh) (01.03.2017)
Get full text
Journal Article
Abstract P2-14-03: “Ethinylestradiol” is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents
Iwase, H, Yamamoto, Y, Murakami, K-I, Yamamoto-Ibusuki, M, Tomita, S, Omoto, Y
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
The High DSS1 Expression Involved in BRCA2 Stability is a Marker for Breast Cancer of Poor Prognosis
Rezano, A., Kuwahara, K., Yamamoto-Ibusuki, M., Kitabatake, M., Moolthiya, P., Suda, T., Tone, S., Yamamoto, Y., Iwase, H., Sakaguchi, N.
Published in Annals of oncology (01.05.2014)
Published in Annals of oncology (01.05.2014)
Get full text
Journal Article
43PTHE HIGH DSS1 EXPRESSION INVOLVED IN BRCA2 STABILITY IS A MARKER FOR BREAST CANCER OF POOR PROGNOSIS
Rezano, A., Kuwahara, K., Yamamoto-Ibusuki, M., Kitabatake, M., Moolthiya, P., Suda, T., Tone, S., Yamamoto, Y., Iwase, H., Sakaguchi, N.
Published in Annals of oncology (01.05.2014)
Published in Annals of oncology (01.05.2014)
Get full text
Journal Article
Abstract P1-14-01: Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior non-steroidal aromatase inhibitor treatment in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR ex study)
Yamamoto, Y, Ishikawa, T, Hozumi, Y, Ikeda, M, Kondo, N, Yamashita, H, Toyama, T, Takashi, C, Saji, S, Yamamoto-Ibusuki, M, Iwase, H
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article